azacitidine has been researched along with Ph 1 Chromosome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, JK; Jiang, L; Li, Q; Luo, Y; Shi, W; Xiao, Y; You, Y; Zhong, ZD | 1 |
| Blanchard, L; Foster, MC; Frank, C; Gallagher, S; Matson, M; Montgomery, N; Muluneh, B; Pepin, K; Vaught, L; Yogarajah, M; Zeidner, JF | 1 |
| Ikezoe, T; Nishioka, C; Nobumoto, A; Tsuda, M; Yang, J; Yokoyama, A | 1 |
| Bueno, MJ; Calin, GA; Cigudosa, JC; Croce, CM; Fernández-Piqueras, J; Gómez de Cedrón, M; Malumbres, M; Pérez de Castro, I; Santos, J | 1 |
| Adès, L; Chait, Y; Cluzeau, T; Dartigeas, C; Delaunay, J; Dreyfus, F; Eclache, V; Fenaux, P; Harel, S; Itzykson, R; Kiladjian, JJ; Quesnel, B; Raffoux, E; Salanoubat, C; Sanhes, L; Seegers, V; Sorin, L; Thepot, S; Turlure, P | 1 |
| Chan, KW; Lockhart, S; McDonald, L; Rytting, M | 1 |
| Chim, CS; Drexler, HG; Fung, TK; Wan, TS; Wong, KF; Wong, KY | 1 |
| Atenafu, EG; Brandwein, JM; Craddock, KJ; Gupta, V; Kennedy, JA; Lipton, JH; Messner, HA; Minden, MD; Schimmer, AD; Schuh, AC; Yee, KW | 1 |
| Garcia-Manero, G; Hoshino, K; Quintás-Cardama, A; Sanchez-Gonzalez, B; Yang, H | 1 |
1 trial(s) available for azacitidine and Ph 1 Chromosome
| Article | Year |
|---|---|
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Disease Progression; Female; France; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Philadelphia Chromosome; Prognosis; Treatment Outcome | 2010 |
8 other study(ies) available for azacitidine and Ph 1 Chromosome
| Article | Year |
|---|---|
Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Azacitidine; Child; Combined Modality Therapy; Decitabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Biopsy; Bone Marrow; Clonal Evolution; DNA Mutational Analysis; Female; Fusion Proteins, bcr-abl; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Philadelphia Chromosome; Treatment Outcome | 2018 |
Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Survival; Dasatinib; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Philadelphia Chromosome; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Xenograft Model Antitumor Assays | 2014 |
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.
Topics: 3' Untranslated Regions; Animals; Azacitidine; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 14; Chromosomes, Mammalian; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Loss of Heterozygosity; Lymphoma, T-Cell; Lymphoproliferative Disorders; Mice; Mice, Inbred C57BL; MicroRNAs; Phenylbutyrates; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-abl; Time Factors; Transfection; Up-Regulation; Whole-Body Irradiation | 2008 |
Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ ALL resolution after decitabine therapy.
Topics: Azacitidine; Benzamides; Child, Preschool; Chromosome Aberrations; Decitabine; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm, Residual; Philadelphia Chromosome; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Stem Cell Transplantation | 2012 |
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Base Sequence; Bone Marrow Neoplasms; Case-Control Studies; Cell Line, Tumor; Demography; DNA Methylation; Female; Humans; Male; MicroRNAs; Middle Aged; Molecular Sequence Data; Myeloproliferative Disorders; Philadelphia Chromosome | 2011 |
Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Combined Modality Therapy; Cytarabine; Decitabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Myeloproliferative Disorders; Philadelphia Chromosome; Registries; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Young Adult | 2013 |
Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia.
Topics: Azacitidine; CpG Islands; Decitabine; DNA Methylation; Humans; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-hck; src-Family Kinases | 2007 |